Advanced Biomed (ADVB) Other financing activities (2024 - 2025)

Advanced Biomed (ADVB) posted Other financing activities of -$5.9 million for Q4 2025, down 190.22% sequentially from $6.6 million in Q3 2025, and down 35127.64% YoY from N/an in Q4 2024.

Advanced Biomed (ADVB) Other financing activities (2024 - 2025) Analysis & Trends

Advanced Biomed has reported Other financing activities for 2 years, with the latest figure at -$5.9 million in Q4 2025.

  • Quarterly Other financing activities fell 35127.64% year-over-year to -$5.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $5.8 million (changed N/A YoY) and the FY2025 annual result came in at $5.5 million, up 6533.02% from the prior year.
  • Other financing activities retreated to -$5.9 million in Q4 2025 per ADVB's latest filing, from $6.6 million in the prior quarter.
  • Over five years, Other financing activities peaked at $6.6 million in Q3 2025 and troughed at -$5.9 million in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn
10 Advanced Biomed 10.43 Mn 10.43 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -5.92 Mn
Dec 31, 2025 -5.92 Mn
Sep 30, 2025 6.56 Mn
Sep 30, 2025 6.56 Mn
Jun 30, 2025 5.16 Mn
Jun 30, 2025 5.16 Mn
Mar 31, 2025 368,279.00
Mar 31, 2025 368,279.00
Dec 31, 2024 -16,800.00
Dec 31, 2024 -16,800.00
Sep 30, 2024 -16,800.00
Sep 30, 2024 -16,800.00